Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06439927

New Method to Close Nasal Septal Perforation

Nasal Septal Perforation Closure Using a 3-dimensional Fabricated Polycaprolactone Nasal Mesh

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
23 (estimated)
Sponsor
Helwan University · Academic / Other
Sex
All
Age
18 Years – 58 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to investigate if a 3-dimensional fabricated nasal mesh works to close nasal septal perforations. Under general anesthesia, during nasal septal perforation repair surgery, the investigator will place the mesh between the elevated mucoperichondrial flaps opposite the site of the perforation and confirm its original position at both sides under nasal endoscope. Endoscopic examination for septal mucosa status will be done monthly for a three months follow up period.

Conditions

Interventions

TypeNameDescription
DEVICEPolycaprolactone nasal mesha 3-dimensional fabricated Polycaprolactone nasal mesh

Timeline

Start date
2024-08-01
Primary completion
2025-09-01
Completion
2025-12-01
First posted
2024-06-03
Last updated
2024-11-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06439927. Inclusion in this directory is not an endorsement.

New Method to Close Nasal Septal Perforation (NCT06439927) · Clinical Trials Directory